InvestorsHub Logo
Followers 18
Posts 1457
Boards Moderated 0
Alias Born 11/01/2018

Re: None

Tuesday, 01/09/2024 6:10:01 PM

Tuesday, January 09, 2024 6:10:01 PM

Post# of 461389
The Steep Climb Ahead For Cassava Sciences' Alzheimer's Drug

Investment Recommendation: "Strong Sell" due to high risks in simufilam's development and a valuation that doesn't align with its bleak clinical prospects.

https://seekingalpha.com/article/4661845-the-steep-climb-ahead-for-cassava-sciences-alzheimers-drug?mailingid=33946122&messageid=must_reads&serial=33946122.1683472&utm_campaign=Must%2BReads%2Brecurring%2B2024-01-09&utm_content=seeking_alpha&utm_medium=email&utm_source=seeking_alpha&utm_term=must_reads
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News